Gilead Forges $375M 10-Year Partnership With Biopharma Co.
Gilead Sciences Inc. said Wednesday it has formed a 10-year, $375 million partnership with Arcus Biosciences Inc., with Gilead paying the company to participate in certain treatment programs and pass various...To view the full article, register now.
Already a subscriber? Click here to view full article